0000899243-23-012066.txt : 20230503 0000899243-23-012066.hdr.sgml : 20230503 20230503151710 ACCESSION NUMBER: 0000899243-23-012066 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230421 FILED AS OF DATE: 20230503 DATE AS OF CHANGE: 20230503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McCarthy Christopher CENTRAL INDEX KEY: 0001975031 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24249 FILM NUMBER: 23883319 MAIL ADDRESS: STREET 1: C/O INTERPACE BIOSCIENCES, INC. STREET 2: 300 INTERPACE PARKWAY; BLDG C, 1ST FLOOR CITY: PARSIPPANY STATE: NJ ZIP: 07054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTERPACE BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001054102 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 222919486 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: MORRIS CORPORATE CENTER 1, STREET 2: BUILDING C, 300 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 412-224-6100 MAIL ADDRESS: STREET 1: MORRIS CORPORATE CENTER 1, STREET 2: BUILDING C, 300 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 FORMER COMPANY: FORMER CONFORMED NAME: Interpace Diagnostics Group, Inc. DATE OF NAME CHANGE: 20151223 FORMER COMPANY: FORMER CONFORMED NAME: PDI INC DATE OF NAME CHANGE: 20021113 FORMER COMPANY: FORMER CONFORMED NAME: PROFESSIONAL DETAILING INC DATE OF NAME CHANGE: 19980129 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2023-04-21 0 0001054102 INTERPACE BIOSCIENCES, INC. IDXG 0001975031 McCarthy Christopher C/O INTERPACE BIOSCIENCES, INC. 300 INTERPACE PARKWAY; BLDG C, 1ST FLOOR PARSIPPANY NJ 07054 0 1 0 0 Principal Financial Officer Common Stock 7310 D Stock Option (right to buy) 6.00 2031-03-10 Common Stock 2500 D Restricted Stock Units 0.00 Common Stock 5000 D One-third of the options will vest and become exercisable on 3/10/2022, and the remaining portion will vest and become exercisable in 24 equal monthly installments commencing on the first day of April 2022, subject to continued employment through each such vesting date. One-third of the restricted stock units will vest commencing on December 1, 2022 and the remaining two-thirds will vest in equal yearly installments thereafter for the next two years. /s/ Christopher McCarthy 2023-05-03